TP53 and colonic neoplasm: As known from previous studies, the top 4 driver mutations in our colon cancer cohort with statistical significance are TP53, KRAS, and APC with PIK3CA (Figure 4B) mutations that are more prevalent in metastatic sites as these are late occurring mutations in CRC.